Clinical trial

Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis

NCT05473520

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-05-24

PhasePHASE3

Study timeline

Study start (actual)2023-05-24Date precision: day

Registry last updated2026-06-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Tuberculosisunresolved

Acute Coronary Syndromeunresolved

Pulmonary Hypertension (Diagnosis)unresolved

Interventions

DoxycyclineDRUG · verified · RxNorm: doxycycline

Sponsors & collaborators

National University Hospital, Singaporelead sponsor

Tan Tock Seng Hospitalcollaborator

Hospital Queen Elizabeth, Malaysiacollaborator

National University of Singaporecollaborator

University Malaysia Sabahcollaborator

Menggatal Health Clinic, Sabah, Malaysiacollaborator

Luyang Health Clinic, Sabah, Malaysiacollaborator

Mapped research locations

SingaporeSingapore1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05473520 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.